Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soldano Ferrone

Showing results (191-200 of 334) with videos related to

Pageof 34
Sort By:
International Journal of Cancer|December 17, 2009
Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genesSara Michel, Michael Linnebacher, Joshua Alcaniz, et al.
Cancer Immunology, Immunotherapy : CII|December 3, 2008
Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cellsTakashi Mine, Satoko Matsueda, Yufeng Li, et al.
Cancer Research|November 5, 2002
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicityDaniela Pende, Paola Rivera, Stefania Marcenaro, et al.
Blood|July 28, 2005
The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactionsGiuseppe Sconocchia, Michelle Lau, Maurizio Provenzano, et al.
Molecular Cancer Therapeutics|November 13, 2008
Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factorsYasufumi Goto, Takaaki Arigami, Minoru Kitago, et al.
Oncotarget|April 22, 2017
Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinomaLei Cai, Theodoros Michelakos, Cristina R Ferrone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
Allorecognition of an HLA-A*01 aberrant allele by an HLA identical family member carrying the HLA-A*0101 alleleIngrid Almeciga, Zhigang Charles Wang, Joaquin Zúñiga, et al.
The Journal of Biological Chemistry|September 19, 2015
Multiple structural and epigenetic defects in the human leukocyte antigen class I antigen presentation pathway in a recurrent metastatic melanoma following immunotherapyChien-Chung Chang, Giuseppe Pirozzi, Shao-Hsuan Wen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2013
SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cellsMichael S Leibowitz, Raghvendra M Srivastava, Pedro A Andrade Filho, et al.
Cancer Research|June 5, 2007
Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastomaLizzia Raffaghello, Paolo Nozza, Fabio Morandi, et al.
Pageof 34

Showing results (191-200 of 334) with videos related to

Sort By:
Pageof 34
International Journal of Cancer|December 17, 2009
Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genesSara Michel, Michael Linnebacher, Joshua Alcaniz, et al.
Cancer Immunology, Immunotherapy : CII|December 3, 2008
Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cellsTakashi Mine, Satoko Matsueda, Yufeng Li, et al.
Cancer Research|November 5, 2002
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicityDaniela Pende, Paola Rivera, Stefania Marcenaro, et al.
Blood|July 28, 2005
The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactionsGiuseppe Sconocchia, Michelle Lau, Maurizio Provenzano, et al.
Molecular Cancer Therapeutics|November 13, 2008
Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factorsYasufumi Goto, Takaaki Arigami, Minoru Kitago, et al.
Oncotarget|April 22, 2017
Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinomaLei Cai, Theodoros Michelakos, Cristina R Ferrone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
Allorecognition of an HLA-A*01 aberrant allele by an HLA identical family member carrying the HLA-A*0101 alleleIngrid Almeciga, Zhigang Charles Wang, Joaquin Zúñiga, et al.
The Journal of Biological Chemistry|September 19, 2015
Multiple structural and epigenetic defects in the human leukocyte antigen class I antigen presentation pathway in a recurrent metastatic melanoma following immunotherapyChien-Chung Chang, Giuseppe Pirozzi, Shao-Hsuan Wen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2013
SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cellsMichael S Leibowitz, Raghvendra M Srivastava, Pedro A Andrade Filho, et al.
Cancer Research|June 5, 2007
Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastomaLizzia Raffaghello, Paolo Nozza, Fabio Morandi, et al.
Pageof 34